Self-Administered Drugs Market - Industry analysis, Trends, Estimation & Forecast, 2016 - 2024

November 2017

 ERC 5777

Drugs administered by the patients without the help of medical professionals are referred to as self-administered drugs. Self-administered drugs such as topical prescription drugs, over-the-counter drugs, and self-administered intravenous drugs are mainly consumed by patients suffering from chronic diseases such as multiple sclerosis, rheumatoid arthritis, diabetes and others. The rising prevalence of chronic diseases globally is expected to boost the demand for self-administered drugs, mainly among the geriatric and working populace. As per WHO, by 2050, the world’s aged population (60 years and older) is expected to reach the 2 billion mark, up from 900 million in 2015.

Market Determinants

The key factor driving the growth of global self-administered drugs market is the increasing outpatient services. The changing life style of people encourages them to opt for outpatient services, which in turn fuels the market growth. Moreover, the rising number of diabetic patients, and the government insurance organizations are also driving the growth of global self-administered drugs market. According to WHO, 422 million adults have diabetes worldwide. Such a huge pool of diabetic patients is expected to increase the demand for self-administered drugs. On the other hand, side effects caused due to improper dosage, along with low or zero reimbursement are hindering the market of self-administered drugs. However, innovations in medical science, and increasing awareness regarding self-administered drugs are expected to create huge opportunities for the growth of market in the upcoming years.

Segment Analysis

The global self-administered drugs market is segmented on the basis of product type, mode of administration, application, and geography. By product type, the market is segmented into injectable drugs, and inhaled drugs. On the basis of mode of administration, the market is mainly segmented into oral, transdermal, intravenous, and nasal. Application wise, the market is segmented into diabetes, hormone replacement, cardiovascular ailment, pain management, osteoporosis, and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the world. Asia-Pacific region is expected to witness fastest growth in the self-administered drugs market owing to the changing lifestyle and growing geriatric population in the region.

Some key vendors in the market are Novartis AG, Bristol-Mayers Squibb, Gilead Sciences, Eli Lilly & Company, Pfizer, Inc., Abbott Laboratories, and Antares Pharma, Inc. In September 2017, Eli Lilly, Geisinger, and Boehringer Ingelheim entered into a major collaboration agreement to develop a risk-prediction model for three serious health consequences associated with type 2 diabetes: heart failure, cardiovascular death, and kidney failure.

SELF-ADMINISTERED DRUGS MARKET SEGMENTATION

By Product type
• Injectable drugs
• Inhaled drugs

By Mode of administration
• Oral
• Transdermal
• Intravenous
• Nasal

By Application
• Diabetes
• Hormone replacement
• Cardiovascular ailment
• Pain management
• Osteoporosis
• Others

By Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World

KEY MARKET PLAYERS

• Novartis AG
• Bristol-Mayers Squibb
• Gilead Sciences
• Eli Lilly & Company
• Pfizer, Inc.
• Abbott Laboratories
• Antares Pharma, Inc.

Please fill in the form below to Request for Customized Report

Refresh Captcha

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.


Refresh Captcha

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +1-(908) 379-7709


  help@esticastresearch.com